Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion

Y K Kim1, S Y Lee, S S Kwon

  • 1Department of Internal Medicine, Kangnam St. Mary's Hospital, Catholic University School of Medicine, 505 Banpo-Dong, Seocho-Ku, Seoul 137-040, Korea.

Lung
|March 14, 2002
PubMed

Insights

In pulmonary tuberculosis, T cell responses are lower in the blood but higher in pleural fluid. Elevated levels of interferon-gamma and soluble interleukin-2 receptor in pleural effusion may predict residual pleural thickening after treatment.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • T cell responses are crucial in tuberculosis (TB) pathogenesis.
  • Distinguishing systemic from local immune responses in TB is essential for understanding disease progression and outcomes.
  • Residual pleural thickening (RPT) is a common complication of tuberculous pleural effusion (TPE).

Purpose of the Study:

  • To analyze the differences between systemic and local T cell responses in pulmonary tuberculosis.
  • To investigate the association between pleural fluid immune markers and the development of RPT.
  • To evaluate the utility of interferon-gamma (IFN-γ) and soluble interleukin-2 receptor (sIL-2R) as markers for RPT.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure IFN-γ and sIL-2R levels.
  • Measurements were performed on peripheral blood mononuclear cell (PBMC) culture supernatants and pleural effusion (PE) samples.
  • Study groups included patients with active pulmonary TB (with/without PE), non-TB pleural effusion, and healthy controls.

Main Results:

  • IFN-γ and sIL-2R levels in PBMC supernatants were lower in TB patients compared to healthy controls.
  • Conversely, IFN-γ and sIL-2R levels in PE were higher in TB patients than in non-TB pleural effusion.
  • TB patients with PE had lower PBMC levels of IFN-γ and sIL-2R than those without PE.
  • Higher IFN-γ and sIL-2R levels in PE correlated with lower levels in PBMC supernatants.
  • Patients who developed RPT had significantly higher IFN-γ and sIL-2R levels in their PE.

Conclusions:

  • Diminished systemic Th1 response in TB may result from the sequestration of activated T cells at the disease site.
  • IFN-γ and sIL-2R levels in pleural effusion are potential biomarkers for predicting post-treatment residual pleural thickening.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...